Biochem/physiol Actions
Pralatrexate is an antifolate that selectively enters cancer cells expressing reduced folate carrier type 1 (RFC-1). Pralatrexate potently inhibits DHFR (dihydrofolate reductase).
This product has met the following criteria to qualify for the following awards: